Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 9 to 13, 2020. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 9 to 13, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Statins Tied to Lower In-Hospital COVID-19 Mortality Risk
FRIDAY, Nov. 13, 2020 (HealthDay News) — Treatment with statins prior to and during a COVID-19-related hospitalization is associated with lower COVID-19-related in-hospital mortality, according to a study published online Nov. 2 in the European Heart Journal: Cardiovascular Pharmacotherapy.
ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease
FRIDAY, Nov. 13, 2020 (HealthDay News) — Patients with rheumatic disease have a low incidence of COVID-19 and most have mild disease, according to research presented at ACR Convergence, the annual meeting of the American College of Rheumatology, held virtually from Nov. 5 to 9.
Mental Health ED Visits in Children Up Mid-March to October 2020
FRIDAY, Nov. 13, 2020 (HealthDay News) — From mid-March to October 2020, there was an increase in the proportion of mental health-related emergency department visits among children and adolescents, according to research published in the Nov. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
U.S. Nursing Homes Seeing Increase in New COVID-19 Cases
THURSDAY, Nov. 12, 2020 (HealthDay News) — Nursing homes are seeing an increase in new COVID-19 cases, paralleling an increase in the general U.S. population, according to a report published online Nov. 10 by the American Health Care Association and National Center for Assisted Living.
AHA: Patient CPR Outcomes Similar With COVID-19 Precautions
THURSDAY, Nov. 12, 2020 (HealthDay News) — For patients receiving cardiopulmonary resuscitation, outcomes during COVID-19 were similar to those in 2019, according to a study presented at the American Heart Association Resuscitation Science Symposium 2020, to be held virtually from Nov. 14 to 16 as part of the annual meeting of the American Heart Association.
COVID-19 at Forefront of IDWeek Discussions
THURSDAY, Nov. 12, 2020 (HealthDay News) — Emerging COVID-19 science, including epidemiology, treatments, vaccines, and post-COVID-19 syndrome took center stage at this year’s IDWeek, the annual meeting of infectious disease experts worldwide, held virtually from Oct. 21 to 25. HD Live! sat down with IDWeek chairs Inger Damon, M.D., director of the U.S. Centers for Disease Control and Prevention Division of High-Consequence Pathogens and Pathology, and Tom Talbot, M.D., professor of medicine at the Vanderbilt University School of Medicine in Nashville, Tennessee, to break down the key takeaways of this year’s meeting.
9 Percent Readmitted After Index COVID-19 Hospitalization
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
